RU2012153669A - IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION - Google Patents

IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION Download PDF

Info

Publication number
RU2012153669A
RU2012153669A RU2012153669/15A RU2012153669A RU2012153669A RU 2012153669 A RU2012153669 A RU 2012153669A RU 2012153669/15 A RU2012153669/15 A RU 2012153669/15A RU 2012153669 A RU2012153669 A RU 2012153669A RU 2012153669 A RU2012153669 A RU 2012153669A
Authority
RU
Russia
Prior art keywords
cytostatic
immunosupression
immuno
organism
conditions
Prior art date
Application number
RU2012153669/15A
Other languages
Russian (ru)
Inventor
Наталья Владимировна Масная
Татьяна Юрьевна Краснова
Евгений Юрьевич Шерстобоев
Надежда Валентиновна Исайкина
Галина Ильинична Калинкина
Original Assignee
Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии" Сибирского отделения Российской академии медицинских наук
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии" Сибирского отделения Российской академии медицинских наук filed Critical Федеральное государственное бюджетное учреждение "Научно-исследовательский институт фармакологии" Сибирского отделения Российской академии медицинских наук
Priority to RU2012153669/15A priority Critical patent/RU2012153669A/en
Publication of RU2012153669A publication Critical patent/RU2012153669A/en

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

Применение полифенольных соединений, выделенных из экстракта цветков календулы лекарственной, обладающего иммунокоррегирующим действием на неспецифическую резистентность организма в условиях цитостатической иммуносупрессии.The use of polyphenolic compounds isolated from the extract of the flowers of the medicinal calendula, which has an immunocorrective effect on the nonspecific resistance of the body under conditions of cytostatic immunosuppression.

Claims (1)

Применение полифенольных соединений, выделенных из экстракта цветков календулы лекарственной, обладающего иммунокоррегирующим действием на неспецифическую резистентность организма в условиях цитостатической иммуносупрессии. The use of polyphenolic compounds isolated from the extract of the flowers of the medicinal calendula, which has an immunocorrective effect on the nonspecific resistance of the body under conditions of cytostatic immunosuppression.
RU2012153669/15A 2012-12-11 2012-12-11 IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION RU2012153669A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU2012153669/15A RU2012153669A (en) 2012-12-11 2012-12-11 IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU2012153669/15A RU2012153669A (en) 2012-12-11 2012-12-11 IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION

Publications (1)

Publication Number Publication Date
RU2012153669A true RU2012153669A (en) 2014-06-20

Family

ID=51213643

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012153669/15A RU2012153669A (en) 2012-12-11 2012-12-11 IMMUNO-CORRECTIVE MEANS FOR THE NON-SPECIFIC RESISTANCE OF THE ORGANISM IN THE CONDITIONS OF CYTOSTATIC IMMUNOSUPRESSION

Country Status (1)

Country Link
RU (1) RU2012153669A (en)

Similar Documents

Publication Publication Date Title
CL2016002735A1 (en) Imidazo [4,5-c] quinolin-2-one compounds and their use to treat cancer
CL2016001629A1 (en) Tricyclic compounds as anticancer agents
MX2016016666A (en) Boronic acid derivatives and therapeutic uses thereof.
MA40278A (en) Fatty acids and their use in conjugation to biomolecules
EP3307749A4 (en) Hydrophilic linkers for conjugation
CL2014002873A1 (en) Compounds derived from pyrimidin-amine or triazin-amine, adn-pk inhibitors; pharmaceutical composition; and its use for the treatment of cancer.
WO2016094837A3 (en) Anti-c10orf54 antibodies and uses thereof
JO3433B1 (en) 4-membered ring carboxamamides used as nematicides
UY34657A (en) ? MACROCYCLIC DERIVATIVES FOR THE TREATMENT OF DISEASES ?.
EP4230264A3 (en) Prodrugs of fumarates and their use in treating various deseases
EP3711780A3 (en) Anti-ptk7 antibody-drug conjugates
CL2015002591A1 (en) Chemical entities.
CL2018001171A1 (en) Imidazo [4,5-c] quinolin-2-one compounds and their use in cancer treatment
UY36075A (en) TUBULISINE DERIVATIVES
UY34566A (en) 1,4? DIHYDROPIRIMIDINES 4.4? DISUSTITUTED AND ITS USE AS MEDICINES FOR THE TREATMENT OF HEPATITIS B
WO2015164392A8 (en) Novel anti-rnf43 antibodies and methods of use
CL2016002091A1 (en) Triazine compound and its use for medicinal purposes
WO2014163714A3 (en) Antibody drug conjugates
EP3122757A4 (en) Charged linkers and their uses for conjugation
TR201903026T4 (en) S100A4 ANTIBODIES AND THEIR THERAPEUTIC USES.
AR125920A2 (en) COMPOSITIONS COMPRISING VORTIOXETINE AND DONEPEZIL
TR201910866T4 (en) Combined preparations for cancer treatment.
CL2015002620A1 (en) Pyridin-4-yl derivatives
PH12014502032A1 (en) Treatment of brain cancer
CL2015001202A1 (en) Compounds derived from oxazolidin-2-one-pyrimidine; pharmaceutical composition and combination and use in the treatment of cancer.